HEALTHSTREAM INC shareholders approved Non-binding advisory resolution on executive compensation at the 2026-05-28 meeting.
“FOR AGAINST ABSTAIN BROKER NON VOTES 23,852,346 1,019,058 3,001 2,654,245”
HEALTHSTREAM INC — fact timeline
Source-grounded facts extracted from HEALTHSTREAM INC's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
HEALTHSTREAM INC shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year 2026 at the 2026-05-28 meeting.
“FOR AGAINST ABSTAIN BROKER NON VOTES 27,171,627 355,926 1,097 0”
HEALTHSTREAM INC shareholders approved Election of three Class II directors at the 2026-05-28 meeting.
“FOR WITHHELD BROKER NON VOTES A. Alex Jahangir 22,452,989 2,421,416 2,654,245 Jeffrey L. McLaren 14,484,114 10,390,291 2,654,245 Linda Rebrovick 23,316,490 1,557,915 2,654,245”
Michael M. Collier was appointed as Chief Operating Officer and Executive Vice President at HEALTHSTREAM INC.
“Michael M. Collier has been promoted to the Company’s Chief Operating Officer and Executive Vice President from his prior role as the Company’s EVP, Corporate Strategy, Development & Operations.”
HEALTHSTREAM INC updated its full year 2026 guidance (reaffirmed).
“The Company reaffirms its guidance for 2026 for the measures set forth below as previously announced on February 23, 2026.”
HEALTHSTREAM INC reported first quarter ended March 31, 2026 results: revenue $81.2 million, net income $5.9 million, EPS $0.20 per share (diluted). Guidance reaffirmed.
“healthcare technology platform company for clinical workforce solutions, today announced results for the first quarter ended March 31, 2026 . First Quarter 2026 • Revenues of $81.2 million, up 10.5% from $73.5 million in the first quarter of 2025 , setting a new Company record for quarterly revenue • Operating income of $7.5 million, up 71.6% from $4.4 million in”
HEALTHSTREAM INC amended First Amendment to Amended and Restated Revolving Credit Agreement with Truist Bank (effective 2026-03-13).
“On March 13, 2026, HealthStream, Inc., a Tennessee corporation (the “Company”), and Truist Bank, a North Carolina banking corporation (“Truist”), entered into that certain First Amendment to Amended and Restated Revolving Credit Agreement (the “Amendment”), amending the Amended and Restated Revolving Credit Agreement, dated as of October 6, 2023”
William W. Stead departed as Director at HEALTHSTREAM INC.
“On March 24, 2025, William W. Stead, M.D. notified HealthStream, Inc. (the “Company”) that he has decided not to stand for re-election to the Company’s Board of Directors (the “Board”) as a Class I director at the Company’s annual meeting of stockholders and to retire from service on the Board effective concurrently with this annual meeting.”
Charles E. Beard, Jr. was appointed as Director at HEALTHSTREAM INC.
“On March 7, 2025, the Board of Directors (the “Board”) of HealthStream, Inc. (the “Company”) appointed Charles E. Beard, Jr. as a member of the Board.”
Trisha Coady changed role as EVP, Workforce Development Solutions at HEALTHSTREAM INC.
“On February 24, 2025, the Company also announced in the Earnings Release that Trisha Coady was being promoted to the Company’s EVP, Workforce Development Solutions from her prior role as SVP, Workforce Development Solutions.”
Michael Collier changed role as EVP, Corporate Strategy, Development & Operations at HEALTHSTREAM INC.
“On February 24, 2025, the Company announced in the Earnings Release that Michael Collier was being promoted to the Company’s EVP, Corporate Strategy, Development & Operations from his prior role as the Company’s EVP, Corporate Strategy & Development.”
Michael Sousa resigned as Executive Vice President, Enterprise Applications at HEALTHSTREAM INC.
“On February 24, 2025, HealthStream, Inc. (the “Company”) received notice that Michael Sousa, Executive Vice President, Enterprise Applications intends to resign from his current position at the Company effective March 31, 2025.”
HEALTHSTREAM INC reported first quarter ended March 31, 2024 results: revenue Revenues of $72.8 million in the first quarter of 2024, net income Net income of $5.2 million in the first quarter of 2024, EPS Earnings per share (EPS) of $0.17 per share (diluted) in the first quarter of 2024. Guidance reaffirmed.
“HealthStream, Inc. (the "Company") issued a press release announcing results of operations for the first quarter ended March 31, 2024 and reaffirming guidance for the full year 2024”
HEALTHSTREAM INC reported the full year 2024 results: revenue $292.0 - $296.0 million. Guidance initiated.
“Full Year 2024 Guidance Low High Revenue $ 292.0 - $ 296.0 million Adjusted EBITDA 1 $ 64.5 - $ 67.5 million Capital Expenditures $ 28.0 - $ 30.0 million”
HEALTHSTREAM INC reported the full year ended December 31, 2023 results: revenue $279.1 million, net income $15.2 million, EPS $0.50 per share (diluted). Guidance initiated.
“Full-Year 2023 ● Revenues of $279.1 million, up 5% from $266.8 million in 2022 ● Operating income of $16.0 million, up 29% from $12.4 million in 2022 ● Net income of $15.2 million, up 26% from $12.1 million in 2022 ● Earnings per share (EPS) of $0.50 per share (diluted) in 2023 , compared to $0.39 per share (diluted) in 2022”
HEALTHSTREAM INC reported the fourth quarter ended December 31, 2023 results: revenue $70.6 million, net income $4.6 million, EPS $0.15 per share (diluted). Guidance initiated.
“Fourth Quarter 2023 ● Revenues of $70.6 million, up 3% from $68.5 million in the fourth quarter of 2022 ● Operating income of $4.3 million, up 38% from $3.1 million in the fourth quarter of 2022 ● Net income of $4.6 million, up 87% from $2.5 million in the fourth quarter of 2022 ● Earnings per share (EPS) of $0.15 per share (diluted), up from $0.08 per share (diluted) in the fourth quarter of 2022”
HEALTHSTREAM INC: On October 23, 2023, the Board of Directors approved the amendment and restatement of the Company's Third Amended and Restated Bylaws, including revisions to shareholder nomination mechanics, disclosure requirements, universal proxy rule compliance, and various other updates (effective 2023-10-23).
“On October 23, 2023, the Board of Directors of HealthStream, Inc. (the “Company”) approved the amendment and restatement of the Company’s Third Amended and Restated Bylaws (as so amended, the “Amended and Restated Bylaws”), effectively concurrently with such adoption.”
HEALTHSTREAM INC reported the third quarter ended September 30, 2023 results: revenue $70.3 million, net income $3.9 million, EPS $0.13 per share (diluted). Guidance reaffirmed.
“Revenues of $70.3 million in the third quarter of 2023 , up 5% from $67.3 million in the third quarter of 2022”
HEALTHSTREAM INC incurred revolving credit of $50 million with Truist Bank at base rate plus .50% applicable margin or SOFR plus 1.50% applicable margin maturing October 6, 2026.
“The New Credit Facility consists of revolving loans in the maximum principal amount of $50 million”
HEALTHSTREAM INC amended Amended and Restated Revolving Credit Agreement with Truist Bank., as Administrative Agent for the lenders valued at $50 million (effective 2023-10-06).
“On October 6, 2023, HealthStream, Inc., a Tennessee corporation (the “Company”), entered into an Amended and Restated Revolving Credit Agreement dated as of October 6, 2023, by and among the Company, as Borrower, certain lenders party thereto from time to time, and Truist Bank., as Administrative Agent for the lenders (the “New Credit Agreement”).”
HEALTHSTREAM INC reported Full Year 2023 results: revenue $277.5 - $283.0 million. Guidance reaffirmed.
“The Company reaffirms its guidance for 2023 for the measures set forth below as previously announced on February 20, 2023. For a reconciliation of projected adjusted EBITDA, a non-GAAP financial measure defined later in this release, to projected net income (the most comparable GAAP measure) for 2023, see the table included on page nine of this release. Full Year 2023 Guidance Low High Revenue $ 277.5 - $ 283.0 million Adjusted EBITDA 1 $ 57.5 - $ 60.5 million Capital Expenditures $ 27.0 - $ 29.0 million”
HEALTHSTREAM INC reported the six months ended June 30, 2023 results: revenue $138.1 million, net income $6.8 million, EPS $0.22 per share (diluted).
“For the six months ended June 30, 2023, revenues were $138.1 million, an increase of five percent over revenues of $131.0 million for the first six months of 2022. Operating income for the first six months of 2023 decreased by one percent to $6.9 million, compared to $7.0 million for the first six months of 2022. The decrease in operating income was primarily attributable to higher personnel costs, including severance charges incurred during the six months ended June 30, 2023 due to the previously announced elimination of 33 job roles as a result of several areas of consolidation in connection with restructuring HealthStream’s business under a single platform strategy. Operating income was also impacted by higher expenses, including amortization, software, hosting, contract labor, and travel, which were mostly offset by higher revenues and an increase in capitalized labor associated with software development activities. Net income for the first six months of 2023 increased to $6.8 mill”
HEALTHSTREAM INC reported the second quarter ended June 30, 2023 results: revenue $69.2 million, net income $4.1 million, EPS $0.13 per share (diluted).
“• Revenues of $69.2 million in the second quarter of 2023 , up 5% from $65.6 million in the second quarter of 2022 • Operating income of $4.0 million in the second quarter of 2023 , up 36% from $3.0 million in the second quarter of 2022 • Net income of $4.1 million in the second quarter of 2023 , up 34% from $3.1 million in the second quarter of 2022 • Earnings per share (EPS) of $0.13 per share (diluted) in the second quarter of 2023 , up from $0.10 per share (diluted) in the second quarter of 2022”
Dr. Alex Jahangir was appointed as Director at HEALTHSTREAM INC.
“On May 30, 2023, the Board of Directors (the “Board”) of HealthStream, Inc. (the “Company”) appointed Dr. Alex Jahangir as a member of the Board.”
HEALTHSTREAM INC shareholders approved Advisory vote on executive compensation (say-on-pay) at the 2023-05-25 meeting.
“The shareholders of the Company approved a non-binding advisory resolution on the Company’s executive compensation as described in the Proxy Statement (“say-on-pay”): FOR AGAINST ABSTAIN BROKER NON VOTES 25,542,696 1,518,954 4,784 1,645,930”
HEALTHSTREAM INC shareholders approved Ratification of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-05-25 meeting.
“The shareholders of the Company ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023: FOR AGAINST ABSTAIN BROKER NON VOTES 28,060,070 649,985 2,309 0”
HEALTHSTREAM INC shareholders approved Election of Class II Directors at the 2023-05-25 meeting.
“The shareholders of the Company elected each of the following two directors in Class II for a term of three years and until their successors are duly elected and qualified: FOR WITHHELD BROKER NON VOTES Jeffrey L. McLaren 14,405,364 12,661,070 1,645,930 Linda Rebrovick 20,024,655 7,041,779 1,645,930”
HEALTHSTREAM INC reported the first quarter ended March 31, 2023 results: revenue $68.9 million, net income $2.6 million, EPS $0.09 per share (diluted). Guidance reaffirmed.
“NASHVILLE, Tenn. (April 24, 2023) —HealthStream, Inc. (the "Company") (Nasdaq: HSTM), a leading healthcare technology platform for workforce solutions, announced today results for the first quarter ended March 31, 2023 . First Quarter 2023 • Revenues of $68.9 million in the first quarter of 2023 , up 5% from $65.4 million in the first quarter of 2022 • Operating income of $2.9 million in the first quarter of 2023 , down 28% from $4.0 million in the first quarter of 2022 , which comparison was negatively impacted by a $1.0 million severance charge in the first quarter of 2023 associated with the restructuring of HealthStream's business under a single platform strategy, as further discussed below • Net income of $2.6 million in the first quarter of 2023 , down 9% from $2.9 million in the first quarter of 2022 , which comparison was negatively impacted in the amount of $0.8 million by the severance charge in the first quarter of 2023 associated with HealthStream's restructuring referenced”
Michael D. Shmerling departed as Class II Director at HEALTHSTREAM INC.
“On March 27, 2023, Michael D. Shmerling notified HealthStream, Inc. (the “Company”) that he has decided not to stand for re-election to the Company’s Board of Directors (the “Board”) as a Class II director at the Company’s 2023 annual meeting of stockholders and to retire from service on the Board effective concurrently with this annual meeting.”
Michael J. Sousa was appointed as Executive Vice President, Enterprise Applications at HEALTHSTREAM INC.
“Pursuant to the terms of this Agreement, effective February 20, 2023, Mr. Sousa will serve as the Executive Vice President, Enterprise Applications of the Company, with anticipated increases in responsibilities, and potential future changes in title, over the next five years.”
J. Edward Pearson departed as President & Chief Operating Officer at HEALTHSTREAM INC.
“On February 20, 2023, J. Edward Pearson, President & Chief Operating Officer of HealthStream, Inc. (the "Company"), provided notice to the Company that he will be retiring from his current role in these positions effective at the end of the second quarter of 2023.”
HEALTHSTREAM INC reported the full year ended December 31, 2022 results: revenue $266.8 million, net income $12.1 million, EPS $0.39 per share (diluted). Guidance initiated.
“● Revenues of $266.8 million, up 4% from $256.7 million in 2021 ● Operating income of $12.4 million, up 55% from $8.1 million in 2021 1 ● Net income of $12.1 million, up 107% from $5.8 million in 2021 1 ● Earnings per share (EPS) of $0.39 per share (diluted) in 2022 , compared to $0.18 per share (diluted) in 2021 1”
HEALTHSTREAM INC reported the fourth quarter ended December 31, 2022 results: revenue $68.5 million, net income $2.5 million, EPS $0.08 per share (diluted). Guidance initiated.
“● Revenues of $68.5 million, up 7% from $64.3 million in the fourth quarter of 2021 ● Operating income of $3.1 million, up from an operating loss of $0.5 million in the fourth quarter of 2021 1 ● Net income of $2.5 million, up from a net loss of $0.4 million in the fourth quarter of 2021 1 ● Earnings per share (EPS) of $0.08 per share (diluted), compared to a loss of $0.01 per share (diluted) in the fourth quarter of 2021 1”
Terry Allison Rappuhn was appointed as Director at HEALTHSTREAM INC.
“On January 6, 2022, the Board of Directors (the “Board”) of HealthStream, Inc. (the “Company”) appointed Terry Allison Rappuhn as a member of the Board.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.